Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Nu Holdings
NU
|
+$91.9M |
| 2 |
SW
Smurfit Westrock plc
SW
|
+$76.1M |
| 3 |
Pinduoduo
PDD
|
+$30.9M |
| 4 |
Microsoft
MSFT
|
+$24.9M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$22.8M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$122M |
| 2 |
Apple
AAPL
|
+$45.4M |
| 3 |
WRK
WestRock Company
WRK
|
+$38.2M |
| 4 |
Danaher
DHR
|
+$29M |
| 5 |
Flutter Entertainment
FLUT
|
+$20.3M |
Sector Composition
| 1 | Technology | 32.64% |
| 2 | Healthcare | 12.18% |
| 3 | Consumer Discretionary | 11.62% |
| 4 | Industrials | 9.2% |
| 5 | Communication Services | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Southside Bancshares
SBSI
$919M
| $1.89M | ﹤0.01% |
56,618
| – | – |
|
1902
Vicor
VICR
$2.29B
| $1.89M | ﹤0.01% |
44,832
| – | – |
|
1903
Travere Therapeutics
TVTX
$2.24B
| $1.88M | ﹤0.01% |
134,700
| – | – |
|
|
EXK
1904
Endeavour Silver
EXK
$1.76B
| $1.88M | ﹤0.01% |
476,100
| – | – |
|
1905
Shoals Technologies Group
SHLS
$1.16B
| $1.88M | ﹤0.01% |
334,900
| – | – |
|
|
FBMS
1906
DELISTED
The First Bancshares, Inc.
FBMS
| $1.88M | ﹤0.01% |
58,430
| – | – |
|
1907
Kimbell Royalty Partners
KRP
$1.28B
| $1.88M | ﹤0.01% |
116,600
-6,900
| -6% | -$111K |
|
|
DX
1908
Dynex Capital
DX
$1.64B
| $1.87M | ﹤0.01% |
146,933
| – | – |
|
1909
XPEL
XPEL
$992M
| $1.87M | ﹤0.01% |
43,200
-400
| -0.9% | -$17.3K |
|
1910
FTAI Infrastructure
FIP
$517M
| $1.87M | ﹤0.01% |
200,100
| – | – |
|
1911
Revolve Group
RVLV
$1.7B
| $1.86M | ﹤0.01% |
75,200
| – | – |
|
1912
Origin Bancorp
OBK
$1.1B
| $1.86M | ﹤0.01% |
57,782
| – | – |
|
1913
Janux Therapeutics
JANX
$1.48B
| $1.85M | ﹤0.01% |
40,700
| – | – |
|
1914
Driven Brands
DRVN
$3.03B
| $1.85M | ﹤0.01% |
129,400
| – | – |
|
|
BDN
1915
Brandywine Realty Trust
BDN
$780M
| $1.85M | ﹤0.01% |
339,200
| – | – |
|
|
SII
1916
Sprott
SII
$1.79B
| $1.84M | ﹤0.01% |
42,475
-1,400
| -3% | -$60.8K |
|
1917
Globalstar
GSAT
$3.87B
| $1.84M | ﹤0.01% |
98,904
-1,133
| -1% | -$21.1K |
|
1918
Maravai LifeSciences
MRVI
$401M
| $1.84M | ﹤0.01% |
221,000
| – | – |
|
1919
Lifestance Health
LFST
$2.05B
| $1.83M | ﹤0.01% |
261,400
+36,700
| +16% | +$257K |
|
1920
Soleno Therapeutics
SLNO
$3.03B
| $1.82M | ﹤0.01% |
36,000
+7,200
| +25% | +$364K |
|
|
PLYM
1921
Plymouth Industrial REIT
PLYM
$990M
| $1.82M | ﹤0.01% |
80,400
| – | – |
|
1922
Mativ Holdings
MATV
$672M
| $1.81M | ﹤0.01% |
106,812
| – | – |
|
1923
AMERISAFE
AMSF
$857M
| $1.81M | ﹤0.01% |
37,400
-400
| -1% | -$19.3K |
|
1924
Merchants Bancorp
MBIN
$1.46B
| $1.81M | ﹤0.01% |
40,200
+6,100
| +18% | +$274K |
|
1925
Seaboard Corp
SEB
$3.77B
| $1.8M | ﹤0.01% |
574
| – | – |
|